State of Wyoming Increases Position in Henry Schein, Inc. $HSIC

Key Points

• The State of Wyoming increased its stake in Henry Schein, Inc. by 205.1% during the first quarter, holding 11,335 shares worth approximately $776,000.
• Analyst ratings for Henry Schein vary, with five analysts rating it as a Buy and seven issuing a Hold rating; the average target price is $76.67.
• Henry Schein reported $1.10 earnings per share for the last quarter, missing expectations by $0.09, and projected a fiscal year 2025 EPS guidance of 4.800-4.940.

State of Wyoming lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 205.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,335 shares of the company's stock after acquiring an additional 7,620 shares during the period. State of Wyoming's holdings in Henry Schein were worth $776,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Investment Management Corp VA ADV bought a new position in shares of Henry Schein in the 4th quarter worth about $32,000. Rakuten Securities Inc. bought a new position in shares of Henry Schein in the 1st quarter worth about $34,000. Whittier Trust Co. raised its position in shares of Henry Schein by 714.3% in the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock worth $55,000 after acquiring an additional 700 shares in the last quarter. UMB Bank n.a. raised its position in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after acquiring an additional 201 shares in the last quarter. Finally, Allworth Financial LP raised its position in shares of Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after acquiring an additional 232 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

HSIC has been the subject of a number of research analyst reports. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Wall Street Zen raised Henry Schein from a "hold" rating to a "buy" rating in a research report on Saturday. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research report on Tuesday, May 6th. Finally, Barrington Research decreased their target price on Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research report on Wednesday, August 6th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat, Henry Schein has an average rating of "Hold" and a consensus price target of $76.67.

Henry Schein Stock Down 1.6%

HSIC stock traded down $1.14 during mid-day trading on Tuesday, reaching $68.44. 770,463 shares of the company traded hands, compared to its average volume of 1,757,421. The stock has a market cap of $8.30 billion, a price-to-earnings ratio of 22.08, a P/E/G ratio of 2.30 and a beta of 0.86. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm's 50 day moving average price is $70.31 and its 200 day moving average price is $69.94.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same quarter in the previous year, the firm earned $1.23 EPS. Henry Schein's quarterly revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.